Behçet’s disease market seen reaching $1.8 billion by 2030

Nov. 20, 2026
Behçet’s disease market seen reaching $1.8 billion by 2030
By AI, Created 15:15 UTC, Nov 20, 2026, AGP -

The Behçet’s disease market is projected to grow from $1.24 billion in 2025 to $1.8 billion by 2030 as biologic therapies, earlier diagnosis and rare-disease investment expand treatment demand. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The Behçet’s disease market is tied to a rare, chronic inflammatory condition with limited treatment options and recurring symptoms that can affect the eyes, mouth, skin and genitals. - Rising investment in rare-disease care is expanding research, drug development and treatment access across the category. - The market outlook points to more demand for biologics, early diagnostics and long-term disease management tools.

What happened: - The Business Research Company projects the global Behçet’s disease market will grow from $1.24 billion in 2025 to $1.33 billion in 2026. - The report expects the market to reach $1.8 billion by 2030. - The 2026 report covers market size, trends and forecasts for 2026-2035. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period.

The details: - The 2025-to-2026 increase implies 7.9% annual growth. - The 2026-to-2030 forecast implies 7.8% annual growth. - Growth drivers include heightened awareness of rare diseases, advances in inflammatory disorder treatments, wider corticosteroid use, stronger hospital rheumatology services and greater adoption of immunosuppressant drugs. - Future growth is expected to come from biologic therapies, targeted immune modulation, improved early diagnostic tools and personalized treatment plans. - The report also points to corticosteroid-sparing therapies, long-term disease management strategies and multispecialty care as key trends. - Behçet’s disease is classified as a vasculitis, which means inflammation affects both large and small blood vessels. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics and updated trend analysis. - A free sample is available through the report sample request. - The full report is available at the market report page.

Between the lines: - The rare-disease market is attracting more capital as governments and pharmaceutical companies increase funding, research and development. - Global Genes said companies developing rare-disease treatments raised $7.1 billion in public equity and debt financing in the first quarter of 2024, up 307% from $1.8 billion a year earlier. - The financing surge suggests drug developers and investors see rare-disease therapies as a growing commercial and medical opportunity.

What's next: - The market is expected to keep expanding as biologic treatments and diagnostic tools improve. - The company expects greater use of personalized care and multispecialty treatment models. - Broader rare-disease investment could keep supporting pipeline development and market growth through 2030.

The bottom line: - Behçet’s disease remains a niche but growing market, with treatment innovation and rare-disease funding likely to shape the next phase of expansion.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.